Moreover, loss of ARNT2 leads to an increase of GBM cell proliferation in vivo and ARNT2 overexpression prevents it, implicating ARNT2 may act as a tumor suppressor in GBM. The gene discussed is ARNT2; the disease is glioblastoma.